Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neova is a biotechnology-driven skincare company specializing in DNA repair and copper peptide technologies for dermatological health. Operating as a brand under Niadyne, Inc., the company focuses on mitigating cellular damage caused by UV exposure and environmental stressors. Neova's proprietary formulations utilize liposomal delivery systems to transport active enzymes, such as photolyase and endonuclease, directly into the skin to support natural DNA repair mechanisms. Their research-backed portfolio includes clinical-grade solutions for photoaging, actinic keratosis management, and post-procedure recovery. Neova's products are widely utilized by dermatologists and plastic surgeons, bridging the gap between traditional cosmetics and molecular biology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neova.